newsfilter
← Latest News
ACCESS Newswire·

NLS Pharmaceutics Announces Promising Preclinical Results for Parkinson's Disease Treatments

ZURICH, SWITZERLAND / ACCESSWIRE / June 27, 2024 / NLS Pharmaceutics Ltd. , a Swiss clinical-stage biopharmaceutical company dedicated to pioneering